Real Life Use of Ravulizumab in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria
Clinical trial NCT05274633 · COMPLETED
Trial details
- NCT number
- NCT05274633
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-06-17
- Primary completion
- 2024-06-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.